Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. - Sufficient funds for clinical development activity over the next 24 months; several clinical milestones are scheduled for 2018 and 2019; as Oramed's clinical progress meets our expectations, stock target price remains at NIS 53.2. 2018-08-07 20:00
Pfizer's Breakthrough Innovative Drug IBRANCE(R) (palbociclib) Receives Approval in China 2018-08-07 17:35
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA 2018-08-07 01:15
The first Hong Kong International Summit on Chinese Medicine Concluded Successfully 2018-08-06 16:45
Tan Tock Seng Hospital, the Wound Healing Society Singapore and Zuellig Pharma team up to advance wound care expertise in Singapore 2018-08-06 14:30
Mundipharma's painfocus(TM) Digital Platform Set to Revolutionise Pain Measurement and Management via Artificial Intelligence 2018-08-06 10:29
Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA 2018-08-06 08:00
China Biologic Reports Financial Results for the Second Quarter of 2018 2018-08-04 04:30
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Parkinson's Disease (PD) Patients Whose Symptoms are Uncontrolled With Oral Medication 2018-08-03 19:05
IMPACT Therapeutics Raises $30 Million In Series C Financing 2018-08-03 16:48
Ping An Good Doctor Develops 'One-Minute Consultation + One-Hour Drug Delivery' Network, Covering Thousands of Pharmacies in 80 Cities 2018-08-01 19:58
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA 2018-08-01 18:52
Boehringer Ingelheim achieves modest growth in the first half of 2018 2018-08-01 16:00
I-Mab Biopharma Announces New CFO 2018-08-01 08:44
Envirotainer Opens RAP e2 Station in Toronto, Canada 2018-07-31 19:48
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
Ganovo (R) Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association 2018-07-30 17:42
CStone's MEK Inhibitor CS3006 Receives IND Approval in China 2018-07-30 12:51
Adlai Nortye announces the publication of the Biomarker Analysis From BERIL-1, the Buparlisib study in HNSCC 2018-07-30 11:12
China Biologic Products to Report Second Quarter 2018 Financial Results 2018-07-27 20:00
1 352 353 354 355 356 412